| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $85.22B | $80.72B | $78.07B |
| YoY Revenue Growth % | +5.6% | +3.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $16.88B | $14.96B | $10.89B |
| Operating Margin % | 19.8% | 18.5% | 13.9% |
| Net Income (GAAP) | $14.31B | $12.68B | $9.23B |
| EBITDA (Normalized) | $22.10B | $20.16B | $13.70B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$67.63B | -$19.67B | -$73.42B |
| Capital Expenditures (CapEx) | $6.52B | $6.50B | $3.51B |
| Free Cash Flow (FCF) | -$74.15B | -$26.17B | -$76.93B |
| FCF Margin % | -87.0% | -32.4% | -98.5% |
| Return on Invested Capital (ROIC %) | 1.3% | 1.3% | 12.3% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.10T | $964.61B | $27.15B |
| Total Stockholders' Equity | $212.29B | $208.60B | $55.69B |